Your browser doesn't support javascript.
loading
Chemokine receptor CXCR4 and its ligand CXCL12 expressions and clinical significance in bladder cancer.
Yang, D L; Xin, M M; Wang, J S; Xu, H Y; Huo, Q; Tang, Z R; Wang, H F.
Affiliation
  • Yang DL; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Yunnan Institute of Urology, Kunming, China.
  • Xin MM; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Yunnan Institute of Urology, Kunming, China.
  • Wang JS; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Yunnan Institute of Urology, Kunming, China.
  • Xu HY; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Yunnan Institute of Urology, Kunming, China.
  • Huo Q; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Yunnan Institute of Urology, Kunming, China.
  • Tang ZR; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Yunnan Institute of Urology, Kunming, China.
  • Wang HF; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Yunnan Institute of Urology, Kunming, China.
Genet Mol Res ; 14(4): 17699-707, 2015 Dec 22.
Article in En | MEDLINE | ID: mdl-26782415

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Biomarkers, Tumor / Receptors, CXCR4 / Chemokine CXCL12 Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Genet Mol Res Year: 2015 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Biomarkers, Tumor / Receptors, CXCR4 / Chemokine CXCL12 Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Genet Mol Res Year: 2015 Document type: Article